AJP - Heart Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 278: H1218-H1224, 2000;
0363-6135/00 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (61)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kersten, J. R.
Right arrow Articles by Warltier, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kersten, J. R.
Right arrow Articles by Warltier, D. C.
Vol. 278, Issue 4, H1218-H1224, April 2000

Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmolality

Judy R. Kersten, Wolfgang G. Toller, Eric R. Gross, Paul S. Pagel, and David C. Warltier

Division of Cardiovascular Diseases, Departments of Anesthesiology, Pharmacology, and Medicine, Medical College of Wisconsin and Zablocki Veterans Affairs Medical Center, Milwaukee, Wisconsin 53226

Recent evidence indicates that hyperglycemia is an important risk factor for the development of cardiovascular disease. We tested the hypothesis that myocardial infarct size is related to blood glucose concentration in the presence or absence of ischemic preconditioning (PC) stimuli in canine models of diabetes mellitus and acute hyperglycemia. Barbiturate-anesthetized dogs were subjected to a 60-min period of coronary artery occlusion and 3-h reperfusion. Infarct size was 24 ± 2% of the area at risk (AAR) for infarction in control dogs. PC significantly (P < 0.05) decreased the extent of infarction in normal (8 ± 2% of AAR), but not diabetic (22 ± 4% of AAR), dogs. Infarct size was linearly related to blood glucose concentration during acute hyperglycemia (r = 0.96; P < 0.001) and during diabetes (r = 0.74; P < 0.002) in the presence or absence of PC stimuli. Increases in serum osmolality caused by administration of raffinose (300 g) did not increase infarct size (11 ± 3% of AAR) or interfere with the ability of PC to protect against infarction (2 ± 1% of AAR). The results indicate that hyperglycemia is a major determinant of the extent of myocardial infarction in the dog.

diabetes mellitus; myocardial infarction


This article has been cited by other articles:


Home page
ICVTSHome page
M. Engoren, A. Zacharias, R. H. Habib, T. A. Schwann, C. J. Riordan, S. J. Durham, and A. Shah
The effect of diabetic medications on creatine kinase-myocardial band levels in patients undergoing coronary artery bypass surgery
Interactive CardioVascular and Thoracic Surgery, November 1, 2009; 9(5): 793 - 796.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. N. Peart and J. P. Headrick
Clinical cardioprotection and the value of conditioning responses
Am J Physiol Heart Circ Physiol, June 1, 2009; 296(6): H1705 - H1720.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
R Anantharaman, M Heatley, and C F M Weston
Hyperglycaemia in acute coronary syndromes: risk-marker or therapeutic target?
Heart, May 1, 2009; 95(9): 697 - 703.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Z. Yang, V. E. Laubach, B. A. French, and I. L. Kron
Acute hyperglycemia enhances oxidative stress and exacerbates myocardial infarction by activating nicotinamide adenine dinucleotide phosphate oxidase during reperfusion.
J. Thorac. Cardiovasc. Surg., March 1, 2009; 137(3): 723 - 729.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
T Takahashi, Y Hiasa, Y Ohara, S Miyazaki, K Mahara, R Ogura, H Miyajima, K Yuba, N Suzuki, S Hosokawa, et al.
Acute hyperglycaemia prevents the protective effect of pre-infarction angina on microvascular function after primary angioplasty for acute myocardial infarction
Heart, November 1, 2008; 94(11): 1402 - 1406.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Ascione, C.A. Rogers, C. Rajakaruna, and G.D. Angelini
Inadequate Blood Glucose Control Is Associated With In-Hospital Mortality and Morbidity in Diabetic and Nondiabetic Patients Undergoing Cardiac Surgery
Circulation, July 8, 2008; 118(2): 113 - 123.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
R. Huhn, A. Heinen, N. C. Weber, M. W. Hollmann, W. Schlack, and B. Preckel
Hyperglycaemia blocks sevoflurane-induced postconditioning in the rat heart in vivo: cardioprotection can be restored by blocking the mitochondrial permeability transition pore
Br. J. Anaesth., April 1, 2008; 100(4): 465 - 471.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
C Weston, L Walker, J Birkhead, and National Audit of Myocardial Infarction Project, N
Early impact of insulin treatment on mortality for hyperglycaemic patients without known diabetes who present with an acute coronary syndrome
Heart, December 1, 2007; 93(12): 1542 - 1546.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. Zhong and D. H. Wang
TRPV1 gene knockout impairs preconditioning protection against myocardial injury in isolated perfused hearts in mice
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1791 - H1798.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
E. R. Gross, A. K. Hsu, and G. J. Gross
Diabetes Abolishes Morphine-Induced Cardioprotection via Multiple Pathways Upstream of Glycogen Synthase Kinase-3{beta}
Diabetes, January 1, 2007; 56(1): 127 - 136.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Hassouna, M. Loubani, B. M. Matata, A. Fowler, N. B. Standen, and M. Galinanes
Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium
Cardiovasc Res, February 1, 2006; 69(2): 450 - 458.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Tsang, D. J. Hausenloy, M. M. Mocanu, R. D. Carr, and D. M. Yellon
Preconditioning the Diabetic Heart: The Importance of Akt Phosphorylation
Diabetes, August 1, 2005; 54(8): 2360 - 2364.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. F. LaDisa Jr., J. G. Krolikowski, P. S. Pagel, D. C. Warltier, and J. R. Kersten
Cardioprotection by glucose-insulin-potassium: dependence on KATP channel opening and blood glucose concentration before ischemia
Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H601 - H607.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. D. Solomon, N. S. Anavekar, S. Greaves, J. L. Rouleau, C. Hennekens, M. A. Pfeffer, and HEART Investigators
Angina pectoris prior to myocardial infarction protects against subsequent left ventricular remodeling
J. Am. Coll. Cardiol., May 5, 2004; 43(9): 1511 - 1514.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. R. Gross, J. F. LaDisa Jr., D. Weihrauch, L. E. Olson, T. T. Kress, D. A. Hettrick, P. S. Pagel, D. C. Warltier, and J. R. Kersten
Reactive oxygen species modulate coronary wall shear stress and endothelial function during hyperglycemia
Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1552 - H1559.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Tanaka, F. Kehl, W. Gu, J. G. Krolikowski, P. S. Pagel, D. C. Warltier, and J. R. Kersten
Isoflurane-induced preconditioning is attenuated by diabetes
Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2018 - H2023.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
W. A. Lell, V. G. Nielsen, D. C. McGiffin, F. E. Schmidt Jr, J. K. Kirklin, and A. W. Stanley Jr
Glucose-insulin-potassium infusion for myocardial protection during off-pump coronary artery surgery
Ann. Thorac. Surg., April 1, 2002; 73(4): 1246 - 1251.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. R. Kersten, W. G. Toller, J. P. Tessmer, P. S. Pagel, and D. C. Warltier
Hyperglycemia reduces coronary collateral blood flow through a nitric oxide-mediated mechanism
Am J Physiol Heart Circ Physiol, November 1, 2001; 281(5): H2097 - H2104.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Ramasamy, J. A. Payne, J. Whang, S. R. Bergmann, and S. Schaefer
Protection of ischemic myocardium in diabetics by inhibition of electroneutral Na+-K+-2Cl{-} cotransporter
Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H515 - H522.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. R. Kersten, M. W. Montgomery, T. Ghassemi, E. R. Gross, W. G. Toller, P. S. Pagel, and D. C. Warltier
Diabetes and hyperglycemia impair activation of mitochondrial KATP channels
Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1744 - H1750.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Tanaka, F. Kehl, W. Gu, J. G. Krolikowski, P. S. Pagel, D. C. Warltier, and J. R. Kersten
Isoflurane-induced preconditioning is attenuated by diabetes
Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2018 - H2023.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online